These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1743318)

  • 1. Comparative bioavailability of orally and vaginally administered progesterone.
    Norman TR; Morse CA; Dennerstein L
    Fertil Steril; 1991 Dec; 56(6):1034-9. PubMed ID: 1743318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration.
    Ottoson UB; Carlstrom K; Damber JE; von Schoultz B
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1111-9. PubMed ID: 6498126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the pharmacokinetics of crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women(3).
    Levine H; Watson N
    Fertil Steril; 2000 Mar; 73(3):516-21. PubMed ID: 10689005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo.
    Duijkers IJM; Klingmann I; Prinz R; Wargenau M; Hrafnsdottir S; Magnusdottir TB; Klipping C
    Hum Reprod; 2018 Nov; 33(11):2131-2140. PubMed ID: 30265306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone administration by nasal spray.
    Cicinelli E; Ragno G; Cagnazzo I; Fanelli F; Vetuschi C; Schonauer S
    Fertil Steril; 1991 Jul; 56(1):139-41. PubMed ID: 2065793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.
    Goebelsmann U; Mashchak CA; Mishell DR
    Am J Obstet Gynecol; 1985 Apr; 151(7):868-77. PubMed ID: 3920910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of oral micronized progesterone.
    Maxson WS; Hargrove JT
    Fertil Steril; 1985 Nov; 44(5):622-6. PubMed ID: 4054341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone.
    Simon JA; Robinson DE; Andrews MC; Hildebrand JR; Rocci ML; Blake RE; Hodgen GD
    Fertil Steril; 1993 Jul; 60(1):26-33. PubMed ID: 8513955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of oral micronized progesterone when applied via vaginal route.
    Choavaratana R; Manoch D
    J Med Assoc Thai; 2004 May; 87(5):455-8. PubMed ID: 15222511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of nasally administered progesterone.
    Steege JF; Rupp SL; Stout AL; Bernhisel M
    Fertil Steril; 1986 Oct; 46(4):727-9. PubMed ID: 3758397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of progesterone with different modes of administration.
    Chakmakjian ZH; Zachariah NY
    J Reprod Med; 1987 Jun; 32(6):443-8. PubMed ID: 3612635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay of plasma progesterone after oral administration of micronized progesterone.
    Nahoul K; Dehennin L; Scholler R
    J Steroid Biochem; 1987 Feb; 26(2):241-9. PubMed ID: 3560939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone.
    Archer DF; Fahy GE; Viniegra-Sibal A; Anderson FD; Snipes W; Foldesy RG
    Am J Obstet Gynecol; 1995 Aug; 173(2):471-7; discussion 477-8. PubMed ID: 7645623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micronized progesterone: clinical indications and comparison with current treatments.
    Fitzpatrick LA; Good A
    Fertil Steril; 1999 Sep; 72(3):389-97. PubMed ID: 10519605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
    Hammond GL; Langley MS; Robinson PA; Nummi S; Lund L
    Fertil Steril; 1984 Jul; 42(1):44-51. PubMed ID: 6233179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone.
    Nahoul K; Dehennin L; Jondet M; Roger M
    Maturitas; 1993 May; 16(3):185-202. PubMed ID: 8515718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.